Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sinovac Biotech Ltd (NASDAQ:SVA)

6.10
Delayed Data
As of 4:00pm ET
 -0.01 / -0.16%
Today’s Change
4.38
Today|||52-Week Range
7.16
+6.64%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash91.2M107.2M91.5M65.5M
 
 
 
 
 
Short Term Investment Cash-13.0M16.0M-15.7M-25.9M
 
 
 
 
 
Cash & Short Term Investments91.2M107.2M91.5M65.5M
 
 
 
 
 
 
ReceivablesReceivables23.4M31.9M40.8M39.0M
 
 
 
 
 
 
InventoriesInventories10.5M14.3M18.8M18.7M
 
 
 
 
 
 
Current AssetsPrepaid Expenses1.1M161.0K157.0K352.0K
 
 
 
 
 
Other Current Assets0.003.4M2.4M5.0M
 
 
 
 
Current Assets126.3M157.1M153.7M128.5M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross103.8M96.1M104.2M101.2M
 
 
 
 
 
Depreciation-23.2M-27.5M-34.4M-36.9M
 
 
 
 
 
Intangible Assets1.1M772.0K352.0K--
 
 
 
 
Other Assets1.5M14.8M14.5M9.6M
 
 
 
 
 
Total Assets208.8M240.7M238.5M203.0M
 
 
 
 
 
 
LiabilitiesAccounts Payable2.2M6.1M3.2M1.7M
 
 
 
 
 
Short Term Debt3.3M19.5M50.0M24.2M
 
 
 
 
 
Accrued Expenses7.5M8.7M8.3M9.6M
 
 
 
 
 
Other Current Liabilities16.4M16.6M20.0M25.2M
 
 
 
 
 
Other Liabilities30.2M49.2M79.8M58.0M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt31.2M32.1M1.8M756.0K
 
 
 
 
 
Deferred Taxes-445.6K-117.0K-515.0K-593.0K
 
 
 
 
 
Other Liabilities3.2M0.00482.0K756.0K
 
 
 
 
Total Liabilities75.3M92.3M82.1M59.5M
 
 
 
 
 
 
EquityMinority Interest-3.9M-2.9M-515.0K-861.0K
 
 
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity117.7M128.7M126.6M123.3M
 
 
 
 
 
Total Shareholder Equity117.7M128.7M126.6M123.3M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding55.1M55.6M55.8M56.9M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.